関連する実験動画
Updated: Sep 9, 2025

07:18
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
8.5K
MAPT/tau-secretory lysosomesの障害は,アルツハイマー病患者の認知的脆弱性に関連している
Preeti Sharma1,2, Anuma Pallavi3, Ananya Chatterjee4,5
1Center for Brain Research, Indian Institute of Science, Bangalore, India.
Autophagy
|August 28, 2025
まとめ
ライソーム機能障害は,タウタンパク質の拡散を可能にすることで,アルツハイマー病 (AD) 認知症の進行を促します. リソーム外細胞症を標的とした治療は,AD患者の認知回復力を回復させる可能性があります.
科学分野:
- 神経科学
- 細胞生物学
- 病理学について
背景:
- マイクロチューブル関連タンパク質タウ (MAPT) の拡散は,アルツハイマー病 (AD) 認知症に寄与する.
- AD患者における認知症進行の変動は十分に理解されていません.
研究 の 目的:
- 認知回復力とADの脆弱性におけるリソソーム機能の役割を調査する.
- ADにおけるMAPT/tauの伝播メカニズムを特定する.
主な方法:
- 認知的にレジリエンスの患者と脆弱なAD患者のリゾソーム整合性の比較
- ライソソーム内のMAPT/tau種の分析
- リソーム外細胞症とMAPT/tau分泌の評価
- 性別によるMAPT/tau分泌の比較
主要な成果:
- 認知的にレジリエントなAD患者はリゾソームの完全性を維持し,脆弱な患者はリゾソームの機能不全を示します.
- 脆弱なAD脳内のライソソームには,部分的に消化され,種子に適したMAPT/tau種が含まれています.
- 病原性MAPT/tauはリソソーム外細胞症によって分泌され,増殖と認知機能低下を促進する.
- 女性アルツハイマー病患者は,男性と比較してリソソーム媒介のMAPT/tau分泌が増加している.
結論:
- リンソーム機能不全はADにおける認知症の重度の異質性の根底にある.
- リゾソーム外細胞症とMAPT/tau線維のアミロイド原核をターゲットにすることで,病理を緩和し,認知回復力を促進することができます.
関連する概念動画
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Role of Neurotransmitters in Memory
964
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
964
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K

